Blockchain initiative will enable medical and pharma companies to fund and accelerate life-saving developments FREMONT, CA / ACCESSWIRE / September 18, 2018 / Verseon (AIM:VSN) today unveils transformative blockchain technology for tokenized securities, developed by its wholly owned subsidiary, BlockRules Ltd. Since its founding in 2002, Verseon's mission remains to develop disruptive technologies and products that advance global health. As part of this goal, the company is challenging...